Researchers from the Faculty of Medicine of the University of Coimbra and researchers from UC-Biotech and biotechnology companies from Biocant Park gathered on the 22nd of March to share the main strategic lines and the vision of these institutions in order to strengthen their relationship and promote future partnerships.
Clinical trial in ischemic stroke
A consortium envolving our group, Criostaminal and Hospital Rovisco Pais will start a clinical trial for the application of a cell-based therapy (with cells isolated from the bone marrow) for the treatment of ischemic stroke. https://www.tsf.pt/lusa/interior/investigadores-de-coimbra-vao-utilizar-celulas-estaminais-para-recuperar-doentes-de-avc-9086578.html
Congratulations to Miguel Lino
Miguel Lino has received the best poster award with the poster entitled "Spatio-temporal controlled delivery of miRNAs for modulation of cell activity" at the 10th International Meeting of the Portuguese Society of Stem Cells and Cell Therapies, held in Covilhã from the 12th to the 14th of October.
Lino Ferreira and Patrícia Pitrez interviewed on “90 segundos de ciência”
Lino Ferreira talked about the CardioStem project, which is focused on the development of new cell therapies and in vitro cardiac tissue to study new drugs for cardiac repair. http://www.90segundosdeciencia.pt/episodes/ep-191 Patrícia Pitrez talked abou her project, focused on the study of Progeria, particularly on the vulnerability of smooth muscle cells in this disease. http://www.90segundosdeciencia.pt/episodes/ep-82
Congratulations to Miguel Lino for his PhD
Miguel Lino, PhD student from the doctoral program in Biosciences of the University of Coimbra, defended his PhD on the 20th of June. His thesis was entitled: "Light-triggerable nanomaterials for the delivery of biomolecules"
New work published in PNAS
High-throughput identification of small molecules that affect human embryonic vascular development Link: http://www.pnas.org/content/114/15/E3022.short
New work published in Nature Communications
Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activation Link: https://www.nature.com/articles/ncomms15204